Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 4, 2022
Reporting Period: This filing reports on events occurring on March 4, 2022, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated March 2022) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that the information provided, including the attached investor presentation, is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated March 2022) for actual financial guidance and operational updates, as this 8-K only references the document.
- Confirm that the information in the investor presentation is not legally "filed" under Section 18 of the Exchange Act, limiting liability for forward-looking statements contained therein.
- Check subsequent filings (e.g., 10-Q or 10-K) for the actual financial metrics and performance data for the period ending March 2022.